SOT Therapy for Lyme: Experimental, Costly, and Promising
Supportive Oligonucleotide Therapy (SOT) is an emerging, experimental gene-silencing treatment showing promise for chronic infections like Lyme disease, but it is not yet FDA-approved and requires further research to confirm safety and efficacy.